Acellular Human Lung Scaffolds to Model Lung Disease and Tissue Regeneration
Overview
Authors
Affiliations
Recent advances in whole lung bioengineering have opened new doors for studying lung repair and regeneration using acellular human derived lung tissue scaffolds. Methods to decellularise whole human lungs, lobes or resected segments from normal and diseased human lungs have been developed using both perfusion and immersion based techniques. Immersion based techniques allow laboratories without access to intact lobes the ability to generate acellular human lung scaffolds. Acellular human lung scaffolds can be further processed into small segments, thin slices or extracellular matrix extracts, to study cell behaviour such as viability, proliferation, migration and differentiation. Recent studies have offered important proof of concept of generating sufficient primary endothelial and lung epithelial cells to recellularise whole lobes that can be maintained for several days in a bioreactor to study regeneration. In parallel, acellular human lung scaffolds have been increasingly used for studying cell-extracellular environment interactions. These studies have helped provide new insights into the role of the matrix and the extracellular environment in chronic human lung diseases such as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Acellular human lung scaffolds are a versatile new tool for studying human lung repair and regeneration .
Advancements in lung regeneration: from bench to bedside.
Khayatan D, Barzegar P, Fatima A, Sattar T, Zahid A, Batool S J Transl Med. 2025; 23(1):154.
PMID: 39905476 PMC: 11796163. DOI: 10.1186/s12967-024-05954-6.
Guimaraes L, Brito A, Cereta A, Oliveira A, Afonso J, Mello D Int J Mol Sci. 2024; 25(18).
PMID: 39337615 PMC: 11432310. DOI: 10.3390/ijms251810131.
A roadmap for developing and engineering pulmonary fibrosis models.
Dabaghi M, Carpio M, Saraei N, Moran-Mirabal J, Kolb M, Hirota J Biophys Rev (Melville). 2024; 4(2):021302.
PMID: 38510343 PMC: 10903385. DOI: 10.1063/5.0134177.
The evolution of models of lung fibrosis: promising prospects for drug discovery.
Kolanko E, Cargnoni A, Papait A, Silini A, Czekaj P, Parolini O Eur Respir Rev. 2024; 33(171).
PMID: 38232990 PMC: 10792439. DOI: 10.1183/16000617.0127-2023.
Thiam F, Phogat S, Abokor F, Osei E Respir Res. 2023; 24(1):298.
PMID: 38012580 PMC: 10680329. DOI: 10.1186/s12931-023-02608-x.